catalyst

Rituximab for Schizophrenia Spectrum Disorder (RITS-PS-2019) — primary completion

as of 2026-07-01
at a glance
2022-03-31 · ActualThis event happened.
Synthesized from structured facts only — each point cited above.

Event

What
Rituximab for Schizophrenia Spectrum Disorder (RITS-PS-2019) — primary completion
Type
Trial Readout
Date
2022-03-31
Date type
ACTUAL
Phase
Phase 2
This event happened.
relationships
The graph out of here